Prostatic Neoplasms, Castration-Resistant Completed Phase Trials for Radium Ra-223 (DB12813)

IndicationStatusPhase
DBCOND0001230 (Prostatic Neoplasms, Castration-Resistant)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03563014A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223